Amy H. Tseng
Fondatore presso TissueTech, Inc.
Profilo
Amy H.
Tseng is the founder.
She founded Bio-tissue, Inc. in 1997 and TissueTech, Inc. in 1997.
At TissueTech, Inc., she currently holds the title of Director since 2022.
Ms. Tseng has an MBA from the University of Southern California.
Posizioni attive di Amy H. Tseng
| Società | Posizione | Inizio |
|---|---|---|
TissueTech, Inc.
 TissueTech, Inc. BiotechnologyHealth Technology TissueTech, Inc. develops and manufactures regenerative amniotic tissue-based products. Its products include aminiograft, prokera, cliradex, and neox. It serves ophthalmology, optometry, musculoskeletal, and wound care markets. The company was founded by Amy H. Tseng and Scheffer Tseng in 1997 and is headquartered in Miami, FL. | Fondatore | 01/01/2001 |
Precedenti posizioni note di Amy H. Tseng
| Società | Posizione | Fine |
|---|---|---|
Bio-tissue, Inc.
 Bio-tissue, Inc. Hospital/Nursing ManagementHealth Services Part of TissueTech, Inc., Bio-tissue, Inc. is a biotechnology company that specializes in using human birth tissue to support regenerative healing for ocular surface disease and in surgical, chronic wound, and musculoskeletal applications. The company is based in Miami, FL. The company's portfolio of cryopreserved amniotic membrane products uses its proprietary cryotek® cryopreservation technology, designed to retain the tissues' structural and functional integrity. Bio-tissue is committed to empowering healthcare professionals with solutions to deliver optimal patient outcomes by fostering innovation through evidence-based science. The company was founded in 1997 by Amy H. Tseng, Scheffer C. G. Tseng. Timothy E. Davis has been the CEO of the company since 2022. | Fondatore | - |
Formazione di Amy H. Tseng
| University of Southern California | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
TissueTech, Inc.
TissueTech, Inc. BiotechnologyHealth Technology TissueTech, Inc. develops and manufactures regenerative amniotic tissue-based products. Its products include aminiograft, prokera, cliradex, and neox. It serves ophthalmology, optometry, musculoskeletal, and wound care markets. The company was founded by Amy H. Tseng and Scheffer Tseng in 1997 and is headquartered in Miami, FL. | Health Technology |
Bio-tissue, Inc.
Bio-tissue, Inc. Hospital/Nursing ManagementHealth Services Part of TissueTech, Inc., Bio-tissue, Inc. is a biotechnology company that specializes in using human birth tissue to support regenerative healing for ocular surface disease and in surgical, chronic wound, and musculoskeletal applications. The company is based in Miami, FL. The company's portfolio of cryopreserved amniotic membrane products uses its proprietary cryotek® cryopreservation technology, designed to retain the tissues' structural and functional integrity. Bio-tissue is committed to empowering healthcare professionals with solutions to deliver optimal patient outcomes by fostering innovation through evidence-based science. The company was founded in 1997 by Amy H. Tseng, Scheffer C. G. Tseng. Timothy E. Davis has been the CEO of the company since 2022. | Health Services |
- Borsa valori
- Insiders
- Amy H. Tseng
